Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001209191-16-156108

Director bought 30,000 shares at an average $0.35 ($10,423)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Reynolds Donald Rogers Director 2016-12-16 Purchase +12,700 $0.34 $4,318 12,700 D: show line 1 in the form
Reynolds Donald Rogers Director 2016-12-16 Purchase +7,350 $0.35 $2,573 20,050 D: show line 2 in the form
Reynolds Donald Rogers Director 2016-12-16 Purchase +9,950 $0.36 $3,532 30,000 D: show line 3 in the form
Open-market purchases · 30,000 sh · avg $0.35 · $10,423
Loading xslF345X03/doc4.xml…